549 related articles for article (PubMed ID: 16776932)
1. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of point of care B-type natriuretic peptide testing and GRACE score in patients with acute coronary syndrome].
Sun YH; Wang GL; Fu YY; Xue C; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):716-20. PubMed ID: 20021924
[TBL] [Abstract][Full Text] [Related]
3. Use of B-type natriuretic peptide in evaluation of early percutaneous coronary intervention in patients with acute coronary syndrome.
Jiang CY; Li N; Wang JA
Chin Med J (Engl); 2004 Aug; 117(8):1130-4. PubMed ID: 15361283
[TBL] [Abstract][Full Text] [Related]
4. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
6. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
[TBL] [Abstract][Full Text] [Related]
7. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
8. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
[TBL] [Abstract][Full Text] [Related]
9. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
Kurt IH; Demirkol S; Ünal I; Batur MK
Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
[TBL] [Abstract][Full Text] [Related]
10. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
Bassan R; Tura BR; Maisel AS
Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
[TBL] [Abstract][Full Text] [Related]
12. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients].
Li ZH; Xiao J; Li JZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar; 23(3):179-82. PubMed ID: 21366951
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome.
Montaner J; García-Berrocoso T; Mendioroz M; Palacios M; Perea-Gainza M; Delgado P; Rosell A; Slevin M; Ribó M; Molina CA; Alvarez-Sabín J
Cerebrovasc Dis; 2012; 34(3):240-5. PubMed ID: 23018289
[TBL] [Abstract][Full Text] [Related]
20. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
